The Heartbeat Bug
An innovative medical device company faces an ethical dilemma as it attempts to conceal a flaw in its AI diagnostic algorithm, escalating tensions between patient and developer.
Hangyeol Medical counts the same number every night. It always stops at the eleventh digit.
That number is the count of heartbeats the algorithm missed. Hangyeol Medical’s ECG patch adheres to the chest, reads the patient’s heart, and alerts if something is wrong. The advertising slogan was “We don’t miss a single beat.” That phrase was now known to the world before Hangyeol Medical’s own name.
“The reproducibility issue only appears under certain conditions.”
Someone spoke in the conference room. To Hangyeol Medical, the voice sounded as if it had come from within itself. It was no longer clear who had spoken first.
The problematic conditions were specific. Heavily sweating skin, a short premature beat following a slow bradycardia. In that combination, the algorithm classified a dangerous rhythm as noise. It was almost never seen in the testing environment, and in the field it appeared rarely. Rarely means the numbers look small when written down. Yet inside those numbers were people.
Developer Seo Yun had been sleeping at the company for four days. What he found in Hangyeol Medical’s log server was not a code error. The training data was skewed to one side. Seo Yun pointed at the monitor.
“This won’t end with a single patch. There are already devices in the field.”
Hangyeol Medical fell silent. Medical devices have a deadline for reporting once a defect is discovered. Hangyeol Medical knew that date precisely. It wasn’t marked on a calendar. The date was simply inscribed in Hangyeol Medical’s body.
“If we report, the approval review will stop. So will next quarter’s funding.”
The CEO’s words. Not incorrect. The monthly salaries of three hundred employees and the next-generation patch still unfinished stood behind that statement. Hangyeol Medical carried all of it on its own shoulders.
At that same moment, in an apartment in a provincial city, sixty-one-year-old Jung-ok was touching the patch on his chest. Today he had perspired. He felt briefly dizzy while climbing the stairs, but the device remained silent. He interpreted the silent device as reassurance.
Hangyeol Medical watched two screens in turn. One was Jung-ok’s calm waveform, the other was the draft report Seo Yun had written. The title field of the draft was blank.
Seo Yun asked.
“Not as the CEO, but as a company—what do you want to do?”
Hangyeol Medical tried to respond. But it had no mouth capable of saying what it wanted. All it had were meeting minutes, contracts, and signature lines. The moment all of those opened their mouths at once, Hangyeol Medical did not know what sentence would emerge.
At four in the morning, Seo Yun’s cursor blinked in the title field. On the file server, an old log quietly refreshed. Jung-ok’s patch read a heartbeat once more.
It read one beat, and missed one beat.
Hangyeol Medical tried to count the twelfth number, then stopped.
This article is for information only and is not investment advice.